In January the FDA published draft cybersecurity recommendations for marketed medical devices to protect patient safety.

What’s new in this draft FDA guidance document:

Manufacturer’s Responsibilities

This guidance emphasizes that medical device manufacturers should monitor, identify and address cybersecurity vulnerabilities. This draft FDA document highlights that it is essential for device manufacturers to implement comprehensive cybersecurity risk management programs. These programs should focus on addressing the vulnerabilities which could permit the unauthorized access, modification, misuse, or denial of use of information that is stored, accessed, or transferred from a medical device, and could impact patient safety.

Download the FDA Guidance document here: Postmarket Management of Cybersecurity in Medical Devices

You may also be interested in the Pre-market guidance released in 2014

Not sure what to make of these new guidance documents? Talk to our CSV experts about how it may affect your medical device project.

Like it? Share it:

You may also like

Sponsoring & Speaking at 2018 MWSQA Annual Conference
17 June, 2018

We are thrilled to announce another speaking opportunity for Deb Bartel this summer. She will be speaking at the Midwest...

Warning Letter Roundup - January 2017
12 January, 2017

The FDA sends Warning Letters and 483s to companies who significantly violate FDA regulations. We gather those related t...

Are you complying with the European Commission's new version of Annex 16?
23 November, 2015

In October, a new version of Annex 16 was published due to significant changes in the globalization of pharmaceutical su...